Search Results - "Elitzsch, A"

Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions by Laschke, M.W., Elitzsch, A., Vollmar, B., Vajkoczy, P., Menger, M.D.

“…BACKGROUND: Angiogenesis represents the crucial step in the pathogenesis of endometriosis, because endometriotic lesions require neovascularization to…”
Get full text

Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation by Laschke, M W, Elitzsch, A, Scheuer, C, Holstein, J H, Vollmar, B, Menger, M D

“…Background and purpose: Rapamycin is a widely used drug with antifungal, immunosuppressant and antiangiogenic effects. Herein, we studied whether…”
Get full text

In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy by Laschke, Matthias W, Elitzsch, Antje, Vollmar, Brigitte, Menger, Michael D

“…To establish a novel endometriosis model that allows for repetitive in vivo analyses of angiogenesis in ectopic endometrial tissue. Intravital fluorescence…”
Get more information

Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Commentary by FERRERO, S, RAGNI, N, REMORGIDA, V, LASCHKE, M. W, ELITZSCH, A, SCHEUER, C, HOLSTEIN, J. H, VOLLMAR, B, MENGER, M. D

Get full text